Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-18

Clinical Trial Update: Impact of Acthar on Everyday Life of Participants With Severe Keratitis [Phase 4]

View source ↗

Summary

Phase 4 trial updating on the impact of Acthar on daily living for participants with keratitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acthar (repository corticotropin injection)

Snippet

Sponsor: Mallinckrodt | Conditions: Keratitis | Phase 4 | Status: COMPLETED | Results posted: 2021-08-18